VENTANA FOLR1 (FOLR-2.1) RxDx Assay

FDA Premarket Approval P220006

Pre-market Approval Supplement Details

DeviceVENTANA FOLR1 (FOLR-2.1) RxDx Assay
Generic NameImmunohistochemistry Assay, Antibody, Folr1
ApplicantVentana Medical Systems Inc.1910 E. Innovation Park Drivetucson, AZ 85755 PMA NumberP220006 Date Received04/25/2022 Decision Date11/14/2022 Product Code QUL  Advisory Committee Clinical TrialsNCT04296890 Expedited Review Granted? No
Date Received2022-04-25
Decision Date2022-11-14
PMAP220006
SupplementS
Product CodeQUL 
Expedited ReviewNo
Combination ProductNo
Applicant AddressVentana Medical Systems Inc.
1910 E. Innovation Park Drive
tucson, AZ 85755 PMA NumberP220006 Date Received04/25/2022 Decision Date11/14/2022 Product Code QUL  Advisory Committee Clinical TrialsNCT04296890
Expedited Review Granted? No Combination ProductNo Approval Order Statement  
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Is A Qualitative Immunohistochemical Assay Using Mouse Monoclonal Anti-FOLR1, Clone FOLR1-2.1, Intended For Use In The Assessment Of Folate Receptor Alpha (FOLR1) Protein In Formalin-fixed, Paraffin-embedded Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Cancer Tissue Specimens By Light Microscopy. This Assay Is For Use With OptiView DAB IHC Detection Kit For Staining On A BenchMark ULTRA Instrument.FOLR1 Expression Clinical Cut-off Is ? 75% Viable Tumor Cells (TC) With Membrane Staining At Moderate And/or Strong Intensity Levels.This Assay Is Indicated As An Aid In Identifying Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer Who May Be Eligible For Treatment With ELAHERE (mirvetuximab Soravtansine). Test Results Of The VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Should Be Interpreted By A Qualified Pathologist In Conjunction With Histological Examination, Relevant Clinical Information, And Proper Controls.This Product Is Intended For In Vitro Diagnostic (IVD) Use. Approval OrderApproval Order SummarySummary Of Safety And Effectiveness LabelingLabeling
Supplements:  

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 133

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 133
Function: _error_handler

Supplement NumberDateSupplement Type
P220006Original Filing

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.